In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
3 weeks 5 days ago
5 weeks 3 days ago
5 weeks 3 days ago
17 weeks 6 days ago
23 weeks 3 days ago
34 weeks 3 days ago
35 weeks 3 days ago
37 weeks 9 hours ago
37 weeks 4 days ago
37 weeks 6 days ago